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Abstract 
A silicon-on-insulator diode array with a sensitive depth 
of 10 microns has been developed for microdosimetry in 
proton therapy. The detector was coupled to a radiation-hard 
charge sensitive amplifier with the probe assembly capable of 
measuring an LET down to 1.2 keV/ym. The device has been 
successfully tested at two proton therapy centers: The 230 
MeV Northeastern Proton Therapy Center, Boston and the 
250 MeV Proton Medical Research Center at Tsukuba, Japan. 
The device offers much improved spatial resolution compared 
with a proportional gas counter particularly in the critical 
high dose region around the proton Bragg peak. Due to its 
small cross-sectional area (0.04 cm2) measurements may also 
be made in facilities with short high intensity beams. 
I. INTRODUCTION 
Silicon detectors during the last decade have found a wide 
range of applications in radiation oncology. This has been 
greatly assisted by the development of detector systems for 
high energy physics (HEP) in which many advances have 
been made in the areas of radiation hardness and low noise 
multi-channel readout integrated systems. 
In certain applications silicon based detectors offer 
significant advantages particularly with regard to spatia1 
resolution. A new high spatial resolution silicon based 
microdosimeter has been developed using silicon-on-insulator 
(SOI) technology. Previous work characterized the sensitive 
volume and radiation hardness of this detector [1] and its 
performance in boron neutron capture therapy (BNCT) [2, 31. 
The development of an improved low noise 
implementation of this device and testing at two proton 
therapy facilities will be discussed. Experiments were 
conducted at the Proton Medical Research Center (PMRC) at 
University of Tsukuba, KEK, Japan, using a 250 MeV proton 
beam and at the Northeastem Proton Therapy Center 
(NPTC), Boston using a 230 MeV proton beam. 
Proton therapy is a very important radiation oncology 
modality for the treatment of deep-seated tumors [4]. 
Currently, many HEP accelerator centers involved in medical 
programs have dedicated beams for proton therapy and heavy 
ion therapy. The key advantage of proton therapy lies in the 
local delivery of dose at high depths in tissue due to the 
energy loss depth dose profile of high-energy protons in 
matter (Bragg peak). 
Protons interact with matter by continuous slowing down 
as a result of Coulomb collisions with electrons and nuclei, by 
Bremsstrahlung radiation loss, and by nuclear reactions. The 
Coulomb interaction with electrons is the predominant 
mechanism for energy loss and is typically described by the 
electronic stopping power or Linear Energy Transfer (LET, 
dE/dx) of the proton [ 5 ] .  Radiation loss is negligible for the 
energies of interest in proton therapy. However, nuclear 
reactions have a significant effect on the proton beam 
characteristics. The probability that protons will undergo a 
nuclear interaction whilst traversing 1 gm/cm2 is around 1% 
and after 20cm 1 in 4 protons will have suffered a nuclear 
interaction. A NIST report by Seltzer [6] and summarized by 
Miller [4] describes the interactions and products. 
Approximately 21% of the energy lost in slowing down a 250 
MeV proton beam in water is due to nonelastic nuclear 
reactions. This fraction drops to around 4% for a 70 MeV 
beam. Thus nuclear interactions affect the identity and energy 
distribution of the secondary particles and decrease the 
number of orimarv orotons in the beam. 
The radiobiological effectiveness of the beam is dependent 
on the particle types and their energy distribution. An 
important characteristic of the beam is the LET spectrum of 
all primary and secondary particles responsible for the 
radiobiological properties of beam. Experimental 
microdosimetry attempts to quantify the LET spectrum by 
measuring the energy deposited in a cell-sized volume. This 
may then be used to infer radiobiological properties of the 
beam relevant for treatment planning. Thus, microdosimetric 
measurements in a water phantom are important in high 
energy proton therapy installations. Clearly, the relative 
biological effectiveness of the beam varies with depth. A 250 
MeV proton has an initial LET of 0.4 keV/um. This rises 
sharply in the Bragg peak region reaching a maximum value 
of approximately 80 keV/pm within a few microns of the end 
of the range. Microdosimetric measurements, at depths where 
protons enter the Bragg peak region, are particularly 
challenging due to the high spatial resolution required. 
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11. MICRODOSIMETRY DEFINITIONS AND 
SPECTRUM PRESENTATION 
Figure 2: SEM photograph of a portion of the IOxlOKm diode array. 
(Note: Raised sections are aluminum tracks connecting contacts so 
that all diodes are electrically in parallel. The width of the photo is 
about 23pm.) 
Microdosimetric studies of proton beams have been 
performed by several investigators [7- 121. Typically, a 
spherical proportional counter containing a low pressure 
tissue equivalent gas is used to obtain the spectrum of energy 
deposition events [ 131. The millimeter resolution required in 
the Bragg peak region is not achievable using such a counter 
which normally has a diameter of 1-2 cm. The large size of 
the counter also creates problems with pileup effects due to 
simultaneous multiple events during high DC current 
operation or when the proton beam consists of large currents 
produced in nanosecond to microsecond pulses. 
Measurements of microdosimetric spectra using a 
proportional counter have been reported with count rates as 
low as 350 countslsec still exhibiting pileup due to the large 
size of the counter [IO]. Therefore, proton microdosimetry 
requires small microdosimeters with high spatial resolution 
(clmm) and small collection areas along with a short 
collection time in the tens of nanosecond range. Analysis of 
the pulse time structure of the beam current is important for 
correct measurements of microdosimetry spectra. 
The energy deposited in a microdosimeter is amplified 
and recorded by a multi-channel analyzer to produce a 
spectrum of the number of events recorded at different 
energies. Experimental microdosimetry then introduces the 
concept of lineal energy y (in keV/pm) which provides a 
crude measure of particle LET. Lineal energy is defined as 
where E is the energy imparted in the volume of interest by 
an energy deposition event and is the mean chord length of 
the volume [13]. Ionizing particles intercepting the volume 
will produce a range of chord lengths and i is the mean of 
the chord length distribution. Often is calculated assuming 
the sensitive volume is immersed in a uniform isotropic 
fluence of radiation with infinite range [13]. Given a-priori 
information regarding the radiation field one may estimate a 
most appropriate for the irradiation conditions. In our case, 
I = 8.2 pm with the estimation discussed in section 1II.A 
Thus, the energy deposited by each event is divided by the 
mean chord length to give the lineal energy as per equation 
(1). The dose distribution is then given by 
D(Y) OC Y f W  (2) 
where fb) is the lineal energy probability distribution 
calculated from the number of events in the lineal energy 
range interval dy and Db)  is the dose probability density 
distribution [ 131. Note that standard microdosimetry 
nomenclature presents D(y) as d(y) but we use the capital 
form to improve readability and avoid confusing dy and db). 
The dose distribution relationship simply reflects the fact that 
higher lineal energies deposit a higher dose. By definition, 
the distribution Db) is normalized to unity: 
We are interested in quite a wide range of lineal energies 
from lkeV/pm to several hundred keV/pm. In this range the 
relative biological effectiveness begins to increase above 
unity. Due to the wide lineal energy range, microdosimetric 
spectra are traditionally presented in a log-linear format, 
which requires further scaling to preserve the dose to area 
correspondence. In summary, all microdosimetric spectra are 
presented in the standard yD(Y)m yyb)  versus log&) format. 
The ordinate is displayed as yD(v) on a linear-log plot since 
jD(Y)dY = ln(lO)jYD(Y)d(logY) (4) 
and this integral is proportional to the dose deposited in the 
interval dy. Presented in this way, equal areas under different 
regions of the function yD(Y) correspond to equal doses. 
To convert to tissue equivalent (TE) microdosimetric 
spectra the f of the silicon device is simply scaled by a factor 
of 1/0.63. A previous paper by Bradley [ 141 has addressed the 
issue of tissue equivalency of silicon based microdosimetric 
measurements for BNCT [2, 31. The results are also 
applicable for energy deposition through coulomb interactions 
by higher energy protons. It was demonstrated [ 141 that under 
appropriate geometrical scaling (dimensions multiplied by 
1/0.63) silicon detectors with well known geometry will 
record energy deposition spectra representative of tissue cells 
of equivalent shape. Note, that the study neglected nuclear 
reactions in the silicon since the incident charged particles, 
particularly protons, will be much more frequent. In this 
paper, with an emphasis on device operation, we present all 
results based on the silicon mean chord length without TE 
correction. 
111. METHODS 
A .  New Silicon Microdosimeter 
collection via diffusion from outside of the depletion region. 
By using SO1 structures, we preclude any charge collection 
from beneath the SO1 layer due to the underlying insulating 
layer of SOz. Such a design creates a sensitive volume of 
well-defined depth. 
The SO1 diode test structures were fabricated on bonded 
SO1 wafers with thickness 2, 5, and 10 pm. In addition, a 
bulk device (no SOI) was fabricated. Several diode array 
structures are available on each device. For this study, the 10 
pm SO1 device was used to provide a large sensitive volume 
and best possible signal to noise ratio. The array consisted of 
120x40=4800 diodes with each diode having a junction size 
of lOxlOpm. The total size of each diode cell was 3Ox3Opm 
giving an array area of 0.044 cm2. Note that all diodes in a 
given array are connected in parallel. The n+ and p+ silicon 
layers with depths 0.2 and 0.5 pm were constructed by 
arsenic and boron implantations at 30keV and 5~10'~cm-*.  
The impurity concentration of the P type silicon was 
1 . 5 ~ 1 0 ' ~ c m - ~ .  The device is packaged in a 28 Pin DIL 
ceramic carrier. Figure 1 shows the over-layer and detailed 
device cross-section whilst Figure 2 is a SEM photograph of a 
portion of the small array. 
The sensitive volume of the device and its radiation 
hardness were determined by alpha spectroscopy and ion- 
microbeam experiments using methods outlined in previous 
work by us [l]. The device bias was set to 1OV so that the 
depletion depth is approximately 3 pm. Hence the 10 pm SO1 
is not fully depleted and charge collection occurs via diffusion 
as well as drift processes. For the 10 pm device, the charge 
collection efficiency was found to vary from about 0.79 in 
regions most distant from a diode junction to 0.86 in the 
center of a junction where drift collection is strongest. This 
relatively small variation is a result of the large minority 
carrier diffusion length (61 pm) in comparison to the cell 
dimensions (30x30~1 Opm). Therefore, the collection 
efficiency may be reasonably approximated by a constant 
value of 0.82. 
The silicon microdosimeter consists of a SO1 diode array 
test structure fabricated by Fujitsu Research Laboratories 
Ltd.[ 151. The application requires: 
Microdosimetric spectra require an estimate of the 
detectors mean chord length 7 .  An accurate value of 7 may 
be obtained via Monte-Carlo simulation methods which 
An accurately defined sensitive volume (region of charge 
collection). Minimization of charge collection complexity 
in particular diffusion and funneling effects. 
An array of identical diodes to improve collection 
statistics. 
Diode structure sizes of the order of a few microns to 
simulate biological cells with typical cell diameters of 10- 
15pm. 
transport the protons and other charged particles through the 
experimental setup and determine the path length traversed 
through the device. However, a reasonable first order 
approximation assumes that the beam is largely normal to the 
diode surface in which case we may approximate - 8.2pm. 
Two different probe assemblies are used in this work 
corresponding to different stages in the project development: 
Prototype assembly #1: This probe was the first _ _  
Capable of measuring an LET down to about 1 keV/pm. 
Above this value of LET the radiobiological effectiveness 
begins to rise above 1. 
assembly constructed and consists of the microdosimeter 
package inserted into a machined Lucite holder with a 1 m 
coaxial cable connecting the detector to a Canberra 2003T 
charge sensitive preamplifier (CSA) as shown in Figure 3. 
An ideal silicon based microdosimeter collects charge in a Noise was minimized by encapsulating the entire 
microdosimeter probe in an aluminum foil shielding which 
was then connected to the coaxial cable ground. This also 
reverse-biased p-n junction diode via drift driven separation 
of electron hole pairs in the depletion region. In reality, 
charge collection is complicated by additional charge 
1389 
ensured that the chip did not receive any light, which 
generates significant noise via surface photo-generation. 
An 8-meter coaxial cable links the preamplifier to a 
Canberra 2024 Fast Spectroscopy amplifier. The output of 
this amplifier is a voltage pulse whose amplitude is 
proportional to the energy deposited in the sensitive volume 
of the microdosimeter. Note that the microdosimeter collects 
charge generated by the traversal of an ion through the 
device’s sensitive volume. The charge collected is 
proportional to the energy deposited, as it requires 3.6 eV to 
generate an electron hole pair in silicon. The pulse height 
from each event is digitized and stored using a PC based 
Multi-Channel Analyzer (MCA). 
A two-point calibration giving the gain and offset of this 
system was performed using a polonium-210 alpha 
spectroscopy source with alpha peak energy of 5.301 MeV 
and an Americium-241 alpha-gamma source. The 60 keV 
gamma peak of the Am-241 source was used as a low energy 
reference point to ensure a good estimation of the calibration 
offset. The diode array was replaced by a silicon ion 
implanted detector of similar capacitance, which collects 
charge corresponding to the total energy of the alpha particle. 
Unlike a proportional counter, the silicon diode array does 
not require a high voltage supply. The supply voltage used in 
these experiments was 10 V reverse bias. 
Proton I 
Canberra 20031 
Probe Assembly 
Multi-Channel Analyzer 
Analyser 
Equipment Inside Treatment Room A q u l p m e n t  outside Treatment Room 
Figure 3: Experimental setup for microdosimetry measurements at 
PMRC (Tsukuba) using prototype assembly # I  (original assembly) 
Jam 
le Water Proof Case 
Aluminium Shield 
Equipment inside Trealment Room A q u i p m e n t  outalde Treatment Room 
Prototype assembly #2: The noise performance of the 
first prototype could be significantly improved by removing 
the IOOpF capacitance added by the detector to CSA cable 
and improving shielding to gain immunity to external 
electromagnetic fields (particularly RF interference). The 
second prototype assembly, based on a printed circuit board 
design, uses an AMPTEK A250 radiation-hard CSA in close 
proximity to the detector. All components were selected 
specifically to minimize noise based on our detector 
characteristics. A system view of the low noise prototype is 
shown in Figure 4. 
Fet Modcl 
Figure 5 :  Noise model of microdosimeter and charge sensitive prc- 
amplifier 
In order to optimize the noise performance of the detector 
a noise model of the system was developed as depicted in 
Figure 5. The model considers the primary noise sources as 
the bias resistor Rb and feedback resistor Rf thermal noise; the 
detector current Id shot noise; the thermal noise associated 
with the input transistor channel resistance and the l/f noise 
of the JFET. 
Following standard noise analysis methods such as 
presented by Delaney and Finch [I61 or Radeka [17] we 
arrive at the following expression for the Equivalent Noise 
Charge (ENC) 
where l/RT = l/Rb+l/Rf and Ci,,=Cd+Cg+Cstray, Cd = detector 
capacitance, C, = JFET gate capacitance, C,,,, = stray input 
capacitance, T = shaping time constant of spectroscopy 
amplifier, Kf = l/f noise coefficient, k = Boltzmann’s 
constant and T = temperature (300 K). 
The calculation assumes that the feedback time constant 
(R&J and input time constant (Rb Ci,,) are much greater than 
T and that the buffer and spectroscopy amplifier contribute 
negligible noise. The spectroscopy amplifier frequency 
response is modeled as a simple RC-CR filter 
Figure 4: Experimental setup for microdosimetry measurements at 
NPTC (Boston) using prototype assembly #2 (low noise) 
cut - ~~i~ 
K n  1 + w2z2  
u)z 
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Source 
Rb 
Rf 
Typical values for these components and the relative noise 
contributions are given in Table 1. Therefore minimizing the 
ENC requires selecting a high g, FET with small gate 
capacitance and gate current and maximizing Rb and Rf . We 
select a bias voltage of between 10 and 20V since in this 
range the capacitance is reduced without excessive reverse 
bias current. The 2SK152 FET was selected for its excellent 
gJC, ratio. Due to the presence of high count rates the 
shaping time was normally set to 0.25 ps. 
Actual values of noise measured using an Ortec 414 pulsar 
are 4.7 keV compared with the theoretical estimation of 4.44 
keV. The difference may be attributable to additional leakage 
current on the PCB board, variation in transistor 
specifications and imperfect shielding of the detector from 
external noise sources. Given that lower level discriminator 
settings are typically twice the FWHM we may expect to be 
able to measure down to around 1.1 keV/pm with this device. 
The optimum value of noise would involve paralleling several 
FETs such that the detector and input capacitance matched 
and also adjusting the shaping time to 0.5 ps. A noise level of 
around 300 e rms or 2.5 keV could then be obtained. 
Calibration of this low noise prototype is performed as per the 
older prototype discussed earlier. 
Electrons (RMS) 
100 MR 77 
300 Mi2 45 
Table 1. 
Relative contribution of noise components in microdosimeter desi n 
1 Noise 1 Relevant Values 1 Noise (z = 0.25 ps) 
Total I 524 erms=4.44 keV 
protons/pulse are transported to the medical beam line. Then 
the beam is momentum filtered and shaped for a 10 x10 cm2 
field. Thus, the beam intensity is around 4 
proton/pulse/device which is much higher than at NPTC. 
This beam presents a difficult experimental challenge even 
when using the small area of the silicon based 
microdosimeter. Clearly, the high luminosity of this beam 
prevents the use of a proportional gas counter for 
microdosimetry due to strong pile up effects. Note that 
reducing the beam current does not reduce pile up effects 
since it usually involves a reduction in the frequency of pulses 
rather than the number of protons per pulse. 
However, to reduce the protons per pulse one can control 
the momentum slit width (X) and vertical slit width (Y) 
which are typically set to 150 and 30 mm respectively. 
B. Experimental Setup 
The microdosimeter was placed in a 15~15x30 cm3 Lucite 
phantom constructed of 2.5 cm blocks. Such a construction 
allowed the placement of the detector at different positions 
along the beam line axis. To avoid pile-up and ensure a 
constant energy the momentum slit was fixed at X = 3 mm 
whilst the vertical slit was varied from Y = 30 to 2”. 
Microdosimetric spectra at a depth of 17.5 cm were recorded 
at various values of vertical slit width to determine the 
settings required to remove pile-up effects. The acquisition 
time for the measurements was 600 seconds. Measurements at 
various depths in the Lucite phantom were then performed 
having found the beam setup which eliminated pile-up. The 
integral depth-dose was measured by a MOSFET detector. 
Id I 5 n A  I 240 
JFET I K=10-27J, Cg=6pF, I 254 (channel) - -  
(2SK152) I g ,=20mS 1 9 ( l i f )  
Other I z = 0.25 ps, 
IV. EXPERIMENT AT PMRC-TSUKUBA 
A .  Proton Therapy Facility 
The proton therapy facility at PMRC uses the KEK 500 
MeV booster synchrotron as a beam source [ 181. This source 
was originally designed for HEP experiments and since the 
energy and intensity are too high for medical applications, the 
beam energy is degraded down to 250 MeV using carbon 
based degraders. Additional filters reduced this to 200 MeV 
for these experiments. In contrast to the NPTC facility, this 
synchrotron produces 50 ns pulses with an initial 2x109 
protons per pulse. The time interval between pulses is about 1 
second in parasitic beam mode and 0.05 seconds in full beam 
mode. Note that the protons/pulse is the same for both 
parasitic mode and full beam mode. The full beam mode is 
used for patient treatment and provides a dose rate of 
approximately 200 cGy/min. 
The initial beam intensity is reduced by the carbon 
degrader followed by a collimator such that around lo4 
C. Results: Microdosimetric Spectra 
The depth-dose curve obtained using a MOSFET detector 
placed at various depths in the Lucite phantom are shown in 
Figure 6. The advantageous characteristic of a MOSFET 
dosimeter is the extremely small dosimetric volume (-lpm) 
defined by the gate oxide thickness [19, 201. High spatial 
resolution measurements are achievable in the Bragg peak 
regions. However, the response of the MOSFET is dependent 
on the particle LET and angle with respect to the oxide 
electric field. Further investigation and comparison studies 
should be performed to compare the depth-dose derived from 
ionization chambers versus MOSFETs. 
The microdosimetric spectra obtained as a function of 
depth in Lucite are shown in Figure 7. The small peaks from 
30-100 keV/pm are due to statistical uncertainties. The 
general shift in the spectrum to higher lineal energies as 
depth increases from 14 cm to 17.5 cm is evident. The 
MOSFET depth-dose data indicates that at around 17.5 cm 
many of the protons will be approaching the end of their 
range. In this region, the protons have a higher LET, and 
therefore higher lineal energy, as they approach the Bragg 
peak. This behavior is in agreement with results obtained at 
NPTC and by Coutrakon [ 1 11 using a proportional counter. 
The data obtained using the prototype assembly #1 
exhibited significant environmental noise problems 
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particularly when the beam RF was turned on. It is expected 
that the second prototype with its significantly improved 
shielding will avoid such difficulties. The lineal energy could 
not be obtained below 8 keV/pm due to the high noise levels. 
This was the motivation for development of the low noise 
prototype. Despite the limited clinical utility of the 
incomplete spectrum, we may still verify the capability of the 
device in terms of high count-rate performance. 
The vertical slit was adjusted down to 2 mm from the 
normal value of 30 mm in order to avoid pile-up. Figure 8 
shows a comparison of microdosimetric spectrum obtained 
under Parasitic-Beam and Full-Beam modes at PMRC with 
different vertical slit widths (depth in Lucite phantom = 17.9 
cm). This example shows significant pile-up effects using the 
Parasitic Beam despite its much lower total intensity. To 
avoid pile-up in either mode the beam requires a vertical slit 
width of 2 nun in order to reduce the number of protons/spill. 
The spectra of Figure 7 obtained at various depths used such 
a slit arrangement. The results indicate that the low noise 
prototype applied to similar beam conditions should be 
capable of measuring the microdosimetric spectrum down to 
1.2 keV/pm without significant pile-up complications. 
.- Parastic- Bear$3lit3x30mm/'\ 
FulLBearqSlit3xxBOmm \ 
--- FulCBeamSlitbPmm / i 
I .  . .  
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Figure 6: Bragg peak of 200MeV proton beam (PMRC-Tsukuba) 
derived by MOSFET detector in Lucite phantom. Relative dose is 
the dose normalized to maximum dose at depth of 17.4 cm. 
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Figure 7: Microdosimetric spectra of 200MeV proton beam (PMRC- 
Tsukuba) at various depths in a Lucite phantom. Range of proton is 
approximately 18cm. 
V. EXPERIMENT AT NPTC-BOSTON 
A. Proton Therapy Facility 
The new proton therapy facility at NPTC utilizes a 230 
MeV beam extracted from an isochronous cyclotron [21, 221. 
The accelerator was built by Ion Beam Applications (IBA), 
Belgium and has a maximum current of 1.5 pA which is 
hardware limited to 300 nA in order to limit the maximum 
dose rate to the patient. After extraction from the cyclotron 
the beam passes through the Energy Selection System (ESS) 
designed to give a beam of any energy between 70 and 230 
MeV with a user defined momentum width and emittance. 
The ESS uses a rapidly adjustable rotating variable thickness 
of graphite. Slits are provided just after the energy degrader 
to reduce the beam divergence to AE/E<+l%. The facility 
uses a range modulator filter to create the desired spread in 
the proton Bragg peak. A double scattering system using a 
fixed scatterer and a second non-uniform thickness scatterer 
produce a beam with uniform intensity in the lateral profile 
over a 10x10 cm2 field size. 
The NPTC cyclotron operates in continuous wave mode 
using a 106 MHz RF frequency. Acceleration of protons 
occurs within 10-15 degrees of the RF wave. The time 
structure of the beam is therefore semi-DC with a duty-cycle 
of about 10% (30deg/330deg). A typical treatment beam is 2 
nA equivalent to 1.25 x 10" protondsecond. So in a single 
RF cycle of 9.4 ns there are 118 protons spread over 0.8 ns. 
For the case of a 10x10 cm2 field size (obtained using a 
double scattering method) we can expect 1.2 p/cm2/cycle. 
Under these conditions, a microdosimeter should have a small 
cross-sectional area and fast collection time. 
1392 
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B. Experimental Setup 
The microdosimeter selected has an active cross-sectional 
area of 0.044 cm2. The minimum amplifier shaping time 
available was 0.25 ps and the Ortec pile-up reject system was 
employed to eliminate pile-up signals. Note that decreasing 
the amplifier shaping time further would increase noise to 
unacceptable levels. In order to maintain a reasonable dead- 
time (less than about 20%) we require less than 1 proton per 
1.25 ps striking the detector. Such a requirement may be 
fulfilled using a beam current of 0.25 nA in which case we 
expect 0.7 p/ps/(device area). In practice, higher beam 
currents (up to 1 nA) could be employed without excessive 
dead-time and distortion of the spectra due to pile-up events. 
The quick calculations performed above do not include losses 
of beam current due to scattering outside of the beam field. 
The microdosimeter was placed in a Scandtronix water 
tank (Model RFA-300 Plus) which enabled rapid remote 
adjustment of the detector position. The detector position was 
aligned with the center of the beam and microdosimetric 
spectra were recorded at various distances from the beam side 
wall of the tank. At each depth, spectra were recorded using 
two different gains to provide adequate dynamic range in the 
final merged spectrum. Initially the beam current was 
adjusted to ensure that the spectra were not corrupted by pile- 
up events. Furthermore, during measurements, the signal 
prior to the MCA was monitored continuously with an 
oscilloscope to ensure the average interval between pulses 
was reasonable and no pileup was present. The typical 
acquisition time was 600 seconds. 
In addition, measurements of the depth-dose profile in the 
water tank were performed using a Markus ionization 
chamber. Measurements were made every 0.3 cm for the 
range 0-30 cm along the beam axis. 
The proton beam was setup with the energy degrader in 
pass though position and the ESS configured to provide the 
full cyclotron energy of 230.5 MeV with an AE/E of 0.18%. 
The cyclotron energy is attenuated by the items identified in 
Table 2 so that the final energy (calculated using SRIM code 
[23]) of protons entering the water is 191.5 MeV. 
Table 2. 
Beam items in nozzle of NPTC 
Item Material Thick Eout Elost 
(cm) (MeV (MeV 
Ionchambers I Water Eq I 0.304 I 197.0 I 1.4 
Phantom wall I Lucite 1 1  I 191.5 I 5.5  
Water Eq: means that the effective thickness is specified in water 
equivalent terms. The beam spreading filter is made of lead and 
Lexan. 
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Figure 9: Depth-Dose curve for the NPTC 191.5 MeV proton beam 
in water. Relative dose is defined as Dose(Markus)/Maximum 
Dose(Markus). The maximum dose is at 23.2 cm and the relative 
dose = 1 at this point. The depths at which microdosimetric 
measurements are made are shown. 
C. Results: Microdosimetric Spectra 
The microdosimetric spectra obtained as a function of 
depth at NPTC are shown in Figure 10. One first notes the 
significantly improved noise performance of the low noise 
prototype in comparison to measurements made at PMRC. 
Measurements were obtained down to the noise level of about 
1.2 keV/pm. The depth-dose curve obtained using the Markus 
chamber and the microdosimeter measurement positions are 
shown in Figure 9. At depths less than 20cm, the large dose 
contribution from low lineal energy events is due to 
significant high energy proton and gamma contributions 
which both have an LET below 2 keV/pm. As we approach 
the Bragg peak, the LET of the protons rises as seen by the 
increase in the mean lineal energy and the shift of the spectra 
to higher lineal energies at depths between 20-26 cm. These 
effects were also observed using a proportional counter at the 
Loma Linda proton beam by Coutrakon et.al. [l 11 This shift 
is not due to pileup effects since, firstly, the signal was 
continuously monitored with an oscilloscope and, secondly, 
the count rate is lower at higher depths due to beam 
spreading. 
Note the step decline in the microdosimetric spectra at 
around the maximum LET of protons of 78 keV/pm. Dose 
contributions are evident at lineal energies above the 
maximum proton LET due to nuclear reaction products such 
as alpha particles and heavy ion recoils. However, the relative 
number of such events is much smaller than the proton events 
hence the step change above the maximum proton LET. As 
we exceed the maximum range of the protons, the higher 
lineal energy components contribute a relatively higher 
proportion of dose. At 30cm, well past the primary proton 
range, the spectrum is comprised totally of neutron reaction 
products including recoil protons, alpha particles and heavy 
ion recoils. The neutron reaction products tend to have a 
large proportion of dose at higher lineal energies. 
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Figurc 10: Microdosimetric spectra of 191.5 MeV proton beam at 
various depths in a water phantom. Range of proton is 
approximately 23.7 cm. 
VI .  CONCILJSION 
These measurements provide valuable information for 
radiobiological studies of the varying effectiveness of the 
beam as a function of depth. Future work may be directed 
towards the analysis of beam relative biological effectiveness 
such as performed at Loma Linda by Coutrakon et. a1 [ 1 11 at 
a higher spatial resolution than previously attempted. 
In general, pile up and perturbation effects were avoided 
due to the small area (0.04 mi2) of the total pixel array. 
Pileup did occur for experiments at PMRC when the vertical 
momentum slit width was greater than 2 mm. Under these 
conditions, an even smaller area detector is required. The 
detector was coupled to a radiation-hard charge sensitive 
amplifier with the probe assembly capable of measuring an 
LET down to 1.2 keV/pm. The device offers much improved 
spatial resolution compared with a proportional gas counter 
particularly in the critical high dose region around the proton 
Bragg peak. 
We have demonstrated a new approach to microdosimetry 
in radiation oncology using a silicon SO1 p-n junction array 
applied to proton therapy beams. Low noise, small size and 
good radiation hardness facilitate the application of this 
device in radiation oncology. 
VII.  ACKNOWLEDGEMENTS 
The authors would like to thank Shigeo Satoh of Fujitsu 
Research Laboratories for providing the diode array samples 
and the staff of PMRC at Tsukuba and NPTC at Boston for 
their generous time and effort. Electronics support at Boston 
was supplied by J. Bums and R.M. Cataldo whilst at NPTC 
Y. Kohno greatly assisted experiments. Appreciation is 
extended to Jacquelyn Yanch (MIT) who was extremely 
supportive in our trip to Boston. We are also indebted to John 
Burke (University of Wollongong) for his outstanding skills 
in manufacturing the Lucite probes and James Ziegler (IBM) 
for the latest copy of SRIM. This work was funded by 
Australian National Health and Medical Research Council 
Grant No 960804 and an Australian Department of Industry, 
Science and Technology grant. 
VIII. REFERENCES 
P. D. Bradley, A. B. Rosenfeld, K. K. Lee, D. Jamieson, 
G. Heiser, and S. Satoh, “Charge collection and radiation 
hardness of a SO1 microdosimeter for space and medical 
applications,” IEEE Trans. Nucl. Sci., vol. 45, no. 6, pp. 
P. D. Bradley, A. B. Rosenfeld, B. J. Allen, J. Corderre, 
and J. Capela, “Performance of silicon microdosimetry 
detectors in boron neutron capture therapy,” Radiat, 
Res., vol. 151,pp. 235-243, 1999. 
P. D. Bradley, A. B. Rosenfeld, B. J. Allen, T. 
Kobayashi, Y. Sakurai, C.Kota, R. L. Maughan, 
M.Yudelev, J. Coderre, and J. Capala, “Application of 
silicon diode arrays for microdosimetry in BNCT and 
FNT,” 8th International Symposium on Neutron Capture 
Therapy for Cancer, La Jolla, USA, 14-18th Sep 1998, 
1998. 
D. W. Miller, “A review of proton beam radiation 
therapy,” Med. Phys., vol. 22, no. 11, pp. 1943-1954, 
1995. 
International Commission on Radiation Units and 
Measurements, Stopping powers for protons and alpha 
particles (ICRU report 49). Bethesda, Md., U.S.A.: 
ICRU, 1993. 
S. M. Seltzer, An assessment of the role of charged 
secondaries from nonelastic nuclear interactions by 
proton therapy beams in water. Gaithersberg,MD: U.S 
Dept of Commerce, 1993. 
P. J. Kliauga, R. D. Colvett, Y. L. Lam, and H. H. Rossi, 
“The relative effectiveness of 160 MeV protons. I. 
Microdosimetry”,” International Journal of Radiation 
Oncology, Biology, and Physics, vol. 4, pp. 1001-1008, 
1978. 
J. B. Robertson, J. M. Eaddy, J. 0. Archambeau, G. B. 
Coutrakon, D. W. Miller, M. F. Moyers, J. V. Siebers, J. 
M. Slater, and J. F. Dicello, “Relative biological 
effectiveness and microdosimetry of a mixed energy field 
of protons up to 200 MeV,” Adv. Space Res., vol. 14, pp. 
V. P. Cosgrove, A. C. Aro, S. Green, M. C. Scott, G. C. 
Taylor, D. E. Bonnett, and A. Kacperek, “Studies 
relating to 62 MeV proton cancer therapy of the eye,” 
Radiation Protection Dosimetry, vol. 44, pp. 405-409, 
1990. 
2700-2710, 1998. 
271-275, 1994. 
[lO]V. P. Cosgrove, S. Delacroix, S. Green, A. Mazal, and 
M. C. Scott, “Microdosimetric studies on the Orsay 
proton synchrocyclotron at 73 and 200 MeV,” Radiation 
Protection Dosimetry, vol. 70, no. 1-4, pp. 493-496, 
1997. 
1394 
[ 1 11 G. Coutrakon, J. Cortese, A. Ghebremedhin, J. 
Hubbard, J. Johanning, P. Koss, G. Maudsley, C. R. 
Slater, C. Zuccarelli, and J. Robertson, “Microdosimetry 
spectra of the Loma Linda proton beam and relative 
biological effectiveness comparisons,” Med. Phys., vol. 
24, no. 9, pp. 1499-1506, 1997. 
[12]R. Becker, J. Bienen, U. Carl, and P. Cloth, 
“Biophysical investigations of therapeutic proton 
beams,” Radiation Protection Dosimetry, vol. 70, no. 1- 
[13]H. H. Rossi and M. Zaider, Microdosimetry and Its 
Applications. London: Springer, 1996. 
[ 141 P. D. Bradley and A. B. Rosenfeld, “Tissue Equivalence 
Correction for Silicon Microdosimetry Detectors in 
Boron Neutron Capture Therapy,” Med. Phys., vol. 25, 
no. 11, pp. 2220-2225, 1998. 
[15]Y. Tosaka, S. Satoh, K. Suzuki, T. Sugii, N. Nakayama, 
H. Ehara, G. A. Woffinden, and S. A. Wender, 
“Measurements and Analysis of Neutron-Reaction- 
Induced Charges in a Silicon Surface Region,” IEEE 
Trans. Nucl. Sci., vol. 44, no. 2, pp. 173-178, 1997. 
[16]C. F. G. Delaney and E. C. Finch, Radiation Detectors: 
Physical Principles and Applications, 1 ed. Oxford: 
Clarendon Press, 1992. 
[ 171 V. Radeka, “Low-Noise Techniques in Detectors,” Ann. 
Rev. Nucl. Part. Sci., vol. 38,  pp. 217-277, 1988. 
[ 181 T. Matsuda and K. Inamura, “Computer controlled 
multi-leaf conformation radiotherapy,” Nippon Act. 
Radiol., vol. 41, pp. 965-974, 1981. 
[19]A. B. Rosenfeld, M. G. Carolan, G. I. Kaplan, B. J. 
Allen, and V. I. Khivrich, “MOSFET dosimeters: The 
role of encapsulation on dosimteric characteristics in 
mixed gamma-neutron and megavoltage X-ray fields.,” 
IEEE Trans. Nucl. Sci., vol. 42, no. 6, pp. 1870-1877, 
1996. 
[20]A. B. Rosenfeld, G. I. Kaplan, M. G. Carolan, B. J. 
Allen, R. Maughan, M. Yudelev, C. Kota, and J. 
Coderre, “Simultaneous macro-micro dosimetry with 
MOSFETs,” IEEE Trans. Nucl. Sci., vol. 43, no. 6, pp. 
2693-2700, 1996. 
[21]A. Smith, M. Goitein, H. Suit, S. Durlacher, J. Flanz, 
K. Gall, A. Levine, S. Rosenthal, and S. Woods, “The 
Massachusetts General Hospital Northeast Proton 
Therapy Center, Boston Massachusetts,” presented at 
Proceedings of NIRS International Seminar on the 
application of heavy ion accelerator to radiation therapy 
of cancer in connection with XXI PTCOG meeting, 
Chiba, Japan, 1994. 
[22] J. Sisterton, J. B. Flanz, and J. E. Burns, “A new proton 
irradiation facility at the Northeastern Proton Therapy 
Center,”, IEEE Trans. Nucl. Sci., vol. 45, no. 6, 1999. 
[23] J. F. Ziegler, “SRIM: The Stopping and Range of Ions 
in Matter,” , 97.02 ed. Yorktown: IBM Research, 1997. 
4, pp. 485-492, 1997. 
